Little Green Pharma Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Revenue	75.5	82.99	89.61
Revenue Growth	-9.02%	-7.39%	-
Cost of Revenue	35.59	44	41.01
Gross Profit	39.91	38.98	48.59
Selling, General & Admin	16.16	17.63	11.74
Other Operating Expenses	13.23	24.93	15.68
Operating Expenses	31.6	44.32	28.29
Operating Income	8.3	-5.34	20.3
Interest Expense	-0.2	-0.4	-0.19
Interest & Investment Income	0.39	0.41	0.17
Other Non Operating Income (Expenses)	-0.86	-3.81	0.19
EBT Excluding Unusual Items	7.64	-9.14	20.48
Merger & Restructuring Charges	-1.83	-	-
Gain (Loss) on Sale of Assets	-0.54	-0.01	-0.01
Asset Writedown	-0.63	-2.21	-0.07
Pretax Income	4.65	-11.36	20.4
Income Tax Expense	-2.29	-2.14	5.83
Earnings From Continuing Operations	6.94	-9.22	14.56
Earnings From Discontinued Operations	-3.75	-	-
Net Income	3.19	-9.22	14.56
Net Income to Common	3.19	-9.22	14.56
Net Income Growth	-	-	-
Shares Outstanding (Basic)	274	255	-
Shares Outstanding (Diluted)	274	255	-
Shares Change	7.43%	-	-
EPS (Basic)	0.01	-0.04	-
EPS (Diluted)	0.01	-0.04	-
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Free Cash Flow	6.41	1.43	1.11
Free Cash Flow Per Share	0.02	0.01	-
Dividend Per Share	-	0.015	0.010
Dividend Growth	-	50.00%	-
Gross Margin	52.86%	46.97%	54.23%
Operating Margin	11.00%	-6.43%	22.66%
Profit Margin	4.23%	-11.12%	16.25%
Free Cash Flow Margin	8.49%	1.73%	1.24%
EBITDA	9.06	-4.61	20.78
EBITDA Margin	12.00%	-5.56%	23.19%
D&A For EBITDA	0.75	0.72	0.48
EBIT	8.3	-5.34	20.3
EBIT Margin	11.00%	-6.43%	22.66%
Effective Tax Rate	-	-	28.60%